Navigation Links
ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
Date:6/16/2011

SHANGHAI, June 16, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it has been recognized by China's Ministry of Commerce as one of the Top Ten Leading Outsourcing Enterprises in China. The names of the top ten companies were announced at the Fourth Annual China International Service Outsourcing Cooperation Conference, held in Nanjing on June 9 and 10, 2011.

According to the Ministry of Commerce, revenue generated by Chinese outsourcing companies in 2010 rose 14.3% year-over-year to $3.51 billion. The top ten companies generated more than one half of that revenue, showing their strong leadership in the outsourcing services industry. They are mostly in the healthcare, IT, software & services, manufacturing, government, education and finance sectors. The top-10 ranking is based on gross revenue, offshore business revenue, number of employees and average revenue per employee. ShangPharma was one of the only two companies in healthcare sector.

"We are honored to receive this recognition by the Ministry of Commerce," said Mr. Michael Hui, Chairman and CEO of ShangPharma Corporation. "For nearly a decade, ShangPharma has provided a great platform in bridging pioneering global drug research and development trends with China's rich talent and innovative resources. We are proud to be a major player in the fast growing CRO industry in China, and we believe that we are rapidly growing into a world-class company in the pharmaceutical & healthcare industry. We are grateful to the Ministry of Commerce, Shanghai Municipal Commission of Commerce, and local commerce authorities for their generous support of ShangPharma and the outsourcing industry in general. With continued support, we plan to strengthen our service capabilities, develop talent, and build our operations. We are looking forward to further growth as we continue to serve our loyal base of customers globally."

About ShangPharma Corporation ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com. For further information, please contact:ShangPharma Corporation   In Shanghai, China Lan Xie VP of Finance and Operations E-mail: IR@shangpharma.comChristensen In New York, US Kimberly Minarovich, +1 917-533-3268 kminarovich@christensenir.com   In Hong Kong Tip Fleming, +852-9212-0684 tfleming@christensenir.com
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ShangPharma Announces First Quarter 2011 Results
2. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
3. Fox Chase Cancer Center Signs Agreement with Life Technologies Corporation
4. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011
5. China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results
6. Biomerix Corporation Reaches European Distribution Agreement with Cellon S.A.
7. Designed by Kids, Built by Volunteers: Roche, New Jersey Community Development Corporation, and KaBOOM! Build New Playground in Just One Day for Paterson Public School Children
8. Geminus Corporation Named Recipient of Second Annual Netsmart Technologies Customer Innovation Award
9. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
10. DURECT Corporation Announces First Quarter 2011 Financial Results and Update of Programs
11. Techne Corporation Declares Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... developing and commercializing products to treat rare diseases ... today the long-term follow-up data from its Phase ... Innate Defense Regulator (IDR), in the treatment of ... patients undergoing chemoradiation therapy (CRT).  The additional 12-month ...
(Date:12/8/2016)... 8, 2016 Savannah River Remediation LLC ... selected NewTechBio,s NT-MAX Lake & Pond Sludge ... bacteria, in conjunction with Hexa Armor/ Rhombo cover ... National Pollutant Discharge Elimination System requirements. ... steady history of elevated pH levels, above 8.5, ...
(Date:12/8/2016)... , Dec. 8, 2016   Biocept, ... leading commercial provider of clinically actionable liquid biopsy ... announces that clinical data featuring its Target Selector™ ... tissue biopsy for the detection of actionable biomarkers ... from research sponsored by Sara Cannon Research Institute ...
(Date:12/7/2016)... ... December 07, 2016 , ... Huffman Engineering, Inc. ... a Wonderware Certified System Integrator Partner. Huffman Engineering is the only Nebraska-based ... “The System Integrator Partner certification gives customers confidence that our engineers are fully ...
Breaking Biology Technology:
(Date:11/30/2016)... CHICAGO , Nov. 30, 2016  higi ... a new partnership initiative targeting national brands, industry ... and reward their respective audiences for taking steps ... Since its inception in 2012, higi has built ... US, impacting over 38 million people who have ...
(Date:11/29/2016)... France , November 29, 2016 Nearly one ... Continue Reading ... ... is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: ...
(Date:11/22/2016)... , November 22, 2016 According to the ... IRIS, Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), ... published by MarketsandMarkets, the market is expected to grow from USD 10.74 ... CAGR of 16.79% between 2016 and 2022. ... ...
Breaking Biology News(10 mins):